Clinical TrialsSearch results
Number of results: 227
Other
- Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematologic diseases (C-SHOT 0402 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2005-08-29
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Prospective study of Foscarnet sodium administration for the prevention of HHV-6 encephalitis after hematopoietic stem cell transplantation
- Patients with hematologic malignancies, transplanted unrelated cord blood (UCBT) or HLA-one haplotype mismatch graft from a relative (haplo SCT)
- Cellular transplantation biology, Graduate School of Medical Science, Kanazawa University
- 2008-08-30
Recruiting
- Prognostic study of risk stratification among Japanese patients with chronic kidney disease and ischemic heart disease using gated myocardial perfusion SPECT
- Chronic kidney disease, Ischemic heart disease
- Cardiovascular research foundation
- 2009-04-30
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Randomized multi-institutional study for effectiveness of intervention on life style in obese patients with fasting hyperglycemia or abnormal glucose tolerance test.
- Diabetes mellitus (Pre-diabetes )
- All Japan Federation of Social Insurance Associations
- 2009-05-12
Recruiting
- A Phase IIb Study of AZD3427 in Participants with Heart Failure and Pulmonary Hypertension Group 2
- Heart Failure and Pulmonary Hypertension due to Left Heart Disease (WHO Group 2)
- Ageishi Yuji
- 2023-04-13